https://www.live-feeds.com/feed/some-glp-1-companies-facing-lawsuits-over-vision-loss-what-to-knowContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/some-glp-1-companies-facing-lawsuits-over-vision-loss-what-to-knowhttps://www.live-feeds.com/feed/some-glp-1-companies-facing-lawsuits-over-vision-loss-what-to-know#u84412Sat, 26 Sep 2026 00:06:27 +0000Hundreds of patients have filed lawsuits alleging that GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, caused vision loss. The litigation centers on a rare condition described as an eye stroke. While some users report irreversible blindness, the legal actions seek to hold drug companies accountable for these side effects. The cases highlight a potential risk of a rare type of vision loss associated with these popular weight-loss and diabetes treatments.Why it mattersGLP-1 receptor agonists are widely used for weight management and glycemic control. These lawsuits suggest a previous